Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype

Virology Journal

Volumn 8, Issue , 2011, Pages

  Smith, Katherine M ^a   Nanda, Kavita ^a   Spears, Carla J ^a   Ribeiro, Mariana ^b   Vancini, Ricardo ^b   Piper, Amanda ^b   Thomas, Gwynneth S ^a,c   Thomas, Malcolm E ^a   Brown, Dennis T ^b   Hernandez, Raquel ^b  

^a Arbovax Inc   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN E; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; VIRUS PROTEIN; E GLYCOPROTEIN, DENGUE VIRUS TYPE 2; E-GLYCOPROTEIN, DENGUE VIRUS TYPE 2; MUTANT PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ARTICLE; DENGUE VIRUS 2; GENE DELETION; GENETIC TRANSCRIPTION; HOST CELL; HOST RANGE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MUTANT; NONHUMAN; PHENOTYPE; PRIMATE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE; AEDES; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; CHEMICAL STRUCTURE; DENGUE VIRUS; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOGENICITY; PHYSIOLOGY;

ANIMALIA; ARBOVIRUS; AVES; DENGUE VIRUS; EQUIDAE; HEXAPODA; IXODIDA; MAMMALIA; MUS; PRIMATES; VERTEBRATA;

AEDES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; DENGUE VIRUS; HOST SPECIFICITY; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; SEQUENCE DELETION; VIRAL ENVELOPE PROTEINS;

EID: 79958071959     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-289     Document Type: Article

References (49)

1. Dengue and dengue haemorrhagic fever. http://www.who.int/mediacentre/ factsheets/fs117/en/
2. Dengue Virus Pathogenesis: an Integrated View. BEE Martina P Koraka ADME Osterhaus, Clin Microbiol Rev 2009 22 564 581 10.1128/CMR.00035-09 19822889
3. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. W Zhang PR Chipman J Corver PR Johnson Y Zhang S Mukhopadhyay TS Baker JH Strauss MG Rossmann RJ Kuhn, Nat Struct Biol 2003 10 907 912 10.1038/nsb990 14528291 (Pubitemid 37386099)
4. A structural perspective of the flavivirus life cycle. S Mukhopadhyay RJ Kuhn MG Rossmann, Nat Rev Microbiol 2005 3 13 22 10.1038/nrmicro1067 15608696 (Pubitemid 40028466)
5. Exclusion of superinfecting homologous virus by Sindbis virus-infected Aedes albopictus (mosquito) cells. LD Condreay DT Brown, J Virol 1986 58 81 86 3951024 (Pubitemid 16021962)
6. The Utilization of Sterols by Insects. RB Clayton, J Lipid Res 1964 15 3 19 14173327
7. Lipid composition of Sindbis virus. AE David, Virology 1971 46 711 720 10.1016/0042-6822(71)90073-0 4332975
8. Characterization of Semliki Forest virus grown in mosquito cells. Comparison with the virus from hamster cells. A Luukkonen CH von Bonsdorff O Renkonen, Virology 1977 78 331 335 10.1016/0042-6822(77)90105-2 860409 (Pubitemid 8110986)
9. Lipids of cultured mosquito cells (Aedes albopictus). Comparison with cultured mammalian fibroblasts (BHK 21 cells). A Luukkonen M Brummer-Korvenkontio O Renkonen, Biochim Biophys Acta 1973 326 256 261 4797240
10. Cholesterol and the Golgi apparatus. MS Bretscher S Munro, Science 1993 261 1280 1281 10.1126/science.8362242 8362242 (Pubitemid 24081166)
11. Deletions in the transmembrane domain of a sindbis virus glycoprotein alter virus infectivity, stability, and host range. R Hernandez C Sinodis M Horton D Ferreira C Yang DT Brown, J Virol 2003 77 12710 12719 10.1128/JVI.77.23.12710-12719.2003 14610193 (Pubitemid 37430666)
12. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. RM Kinney S Butrapet GJ Chang KR Tsuchiya JT Roehrig N Bhamarapravati DJ Gubler, Virology 1997 230 300 308 10.1006/viro.1997.8500 9143286 (Pubitemid 27211861)
13. A simple method for screening bacterial colonies for mutagenized sites in plasmid DNA. JC Rodriguez-Lecompte MN Nagarajan FS Kibenge, J Virol Methods 2002 99 93 98 10.1016/S0166-0934(01)00387-1 11684307 (Pubitemid 33000387)
14. Quantitation of flaviviruses by fluorescent focus assay. AF Payne I Binduga-Gajewska EB Kauffman LD Kramer, J Virol Methods 2006 134 183 189 10.1016/j.jviromet.2006.01.003 16510196
15. A single deletion in the membrane-proximal region of the Sindbis virus glycoprotein E2 endodomain blocks virus assembly. R Hernandez H Lee C Nelson DT Brown, J Virol 2000 74 4220 4228 10.1128/JVI.74.9.4220-4228.2000 10756035 (Pubitemid 30214428)
16. Exposure to low pH is not required for penetration of mosquito cells by Sindbis virus. R Hernandez T Luo DT Brown, J Virol 2001 75 2010 2013 10.1128/JVI.75.4.2010-2013.2001 11160702 (Pubitemid 32110193)
17. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. DH Mathews J Sabina M Zuker DH Turner, J Mol Biol 1999 288 911 940 10.1006/jmbi.1999.2700 10329189 (Pubitemid 29248642)
18. The PredictProtein server. B Rost G Yachdav J Liu, Nucl Acids Res 2004 32 321 326 10.1093/nar/gkh377 15215403
19. Transmembrane domain-dependent partitioning of membrane proteins within the endoplasmic reticulum. P Ronchi S Colombo M Francolini N Borgese, J Cell Biol 2008 181 105 118 10.1083/jcb.200710093 18391072 (Pubitemid 351519768)
20. Molecular biology of flaviviruses. BD Lindenbach CM Rice, Adv Virus Res 2003 59 23 61 14696326 (Pubitemid 137639363)
21. Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. L Cocquerel C Wychowski F Minner F Penin J Dubuisson, J Virol 2000 74 3623 3633 10.1128/JVI.74.8.3623-3633.2000 10729138 (Pubitemid 30180306)
22. An amphipathic [alpha]-helix at a membrane interface: a structural study using a novel X-ray diffraction method. K Hristova WC Wimley VK Mishra GM Anantharamiah JP Segrest SH White, Journal of Molecular Biology 1999 290 99 117 10.1006/jmbi.1999.2840 10388560 (Pubitemid 29308578)
23. Lehninger principles of biochemistry, Volume 1. D Nelson MMC La, Ney York, NY: W.H. Freeman and Company 2005
24. TE Creighton, Proteins: structures and molecular properties New York: W.H. Freeman 2 1993
25. Transmembrane helices predicted at 95% accuracy. B Rost R Casadio P Fariselli C Sander, Protein Sci 1995 4 521 533 7795533
26. Studies on the nature of dengue viruses,: V. Structure and development of dengue virus in vero cells. T Matsumura V Stollar RW Schlesinger, Virology 1971 46 344 355 10.1016/0042-6822(71)90036-5 4108617
27. Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites. S Welsch S Miller I Romero-Brey A Merz CKE Bleck P Walther SD Fuller C Antony J Krijnse-Locker R Bartenschlager, Cell Host & Microbe 2009 5 365 375 10.1016/j.chom.2009.03.007 21661029
28. PrM- and Cell-Binding Domains of the Dengue Virus E Protein. S Wang R He R Anderson, J Virol 1999 73 2547 2551 9971841 (Pubitemid 29098163)
29. Models of dengue virus infection. DA Bente R Rico-Hesse, Drug Discov Today Dis Models 2006 3 97 103 10.1016/j.ddmod.2006.03.014 18087566
30. Mouse models of dengue virus infection and disease. LE Yauch S Shresta, Antiviral Res 2008 80 87 93 10.1016/j.antiviral.2008.06.010 18619493
31. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. PP Ip F Liao, J Immunol 2010 184 5705 5714 10.4049/jimmunol.0903484 20400703
32. Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. CG Raut RP Deolankar RM Kolhapure MK Goverdhan, Acta Virol 1996 40 143 146 8891094 (Pubitemid 26285109)
33. Prospects for a dengue virus vaccine. SS Whitehead JE Blaney AP Durbin BR Murphy, Nat Rev Microbiol 2007 5 518 528 10.1038/nrmicro1690 17558424 (Pubitemid 46925380)
34. Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. A Yamanaka S Kosugi E Konishi, J Virol 2008 82 927 937 10.1128/JVI.00992-07 18003724
35. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody. CJ Lai AP Goncalvez R Men C Wernly O Donau RE Engle RH Purcell, J Virol 2007 81 12766 12774 10.1128/JVI.01420-07 17881450 (Pubitemid 350156914)
36. Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys. R Putnak DA Barvir JM Burrous DR Dubois VM D'Andrea CH Hoke JC Sadoff KH Eckels, J Infect Dis 1996 174 1176 1184 10.1093/infdis/174.6.1176 8940206 (Pubitemid 26393894)
37. Utilization and metabolism of dietary sterols in the honey bee and the yellow fever mosquito. JA Svoboda MJ Thompson EW Herbert Jr TJ Shortino PA Szczepanik-Vanleeuwen, Lipids 1982 17 220 225 10.1007/BF02535107 7087696
38. Mutations in the endodomain of Sindbis virus glycoprotein E2 define sequences critical for virus assembly. J West R Hernandez D Ferreira DT Brown, J Virol 2006 80 4458 4468 10.1128/JVI.80.9.4458-4468.2006 16611906
39. Dengue virus capsid protein usurps lipid droplets for viral particle formation. MM Samsa JA Mondotte NG Iglesias I Assuncao-Miranda G Barbosa-Lima AT Da Poian PT Bozza AV Gamarnik, PLoS Pathog 2009 5 1000632 10.1371/journal.ppat. 1000632 19851456
40. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. CL Murray CT Jones CM Rice, Nat Rev Micro 2008 6 699 708 10.1038/nrmicro1928
41. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. M Lobigs E Lee, J Virol 2004 78 178 186 10.1128/JVI.78.1.178-186.2004 14671099 (Pubitemid 37549730)
42. Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I. M Lobigs A Mullbacher E Lee, Immunol Cell Biol 2004 82 184 188 10.1046/j.0818-9641.2004.01218.x 15061772 (Pubitemid 38594650)
43. Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent. J Martin L Hermida J Castro Y Romero J Cardosa G Guillen, Curr Microbiol 2009 59 579 583 10.1007/s00284-009-9488-6 19784699
44. Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. DE Clements BA Coller MM Lieberman S Ogata G Wang KE Harada JR Putnak JM Ivy M McDonell GS Bignami ID Peters J Leung C Weeks-Levy ET Nakano T Humphreys, Vaccine 2010 28 2705 2715 10.1016/j.vaccine.2010.01.022 20097152
45. Evaluation of interferences between dengue vaccine serotypes in a monkey model. B Guy V Barban N Mantel M Aguirre S Gulia J Pontvianne TM Jourdier L Ramirez V Gregoire C Charnay N Burdin R Dumas J Lang, Am J Trop Med Hyg 2009 80 302 311 19190230
46. Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys. NJ Marchette T O'Rourke SB Halstead, Med Microbiol Immunol 1980 168 35 47 10.1007/BF02121650 6770237 (Pubitemid 10176603)
47. Guidelines for clinical trials of dengue vaccine in endemic areas. J Hombach, Journal of Clinical Virology 2009 46 7 S9 19800564
48. "Guidelines for the clinical evaluation of dengue vaccines in endemic areas": Summary of a World Health Organization Technical Consultation. R Edelman J Hombach, Vaccine 2008 26 4113 4119 10.1016/j.vaccine.2008.05.058 18597906
49. Characteristics of Sindbis virus temperature-sensitive mutants in cultured BHK-21 and Aedes albopictus (Mosquito) cells. D Renz DT Brown, J Virol 1976 19 775 781 987251